InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

Current share price for ATX : $0.130 0.005 (4%)+

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$67 Amplia Therapeutics - Quarterly Update 12 Aug 2019 8:23AM $0.091 $0.130 risen by 42.86%
$67 Change of Director's Interest - Dr Warwick Tong Rights Issue 5 Aug 2019 7:18PM $0.090 $0.130 risen by 44.44%
$67 Change of Director's Interest - Dr Chris Burns, Rights Issue 5 Aug 2019 7:15PM $0.090 $0.130 risen by 44.44%
$67 Change of Director's Interest - Andrew Cooke, Rights Issue 5 Aug 2019 7:14PM $0.090 $0.130 risen by 44.44%
$67 Appendix 4C - Quarterly Cash Flow Report - June 2019 Qtr 31 Jul 2019 5:32PM $0.125 $0.130 risen by 4%
$67 RightsIssue Participation Supports Clinical-Enabling Studies 31 Jul 2019 3:19PM $0.120 $0.130 risen by 8.33%
$67 Amplia Therapeutics - Bioshares Presentation July 2019 25 Jul 2019 4:36PM $0.120 $0.130 risen by 8.33%
$67 Appendix 4G - Key to Corporate Governance Disclosures 25 Jul 2019 4:35PM $0.120 $0.130 risen by 8.33%
$67 2019 Corporate Governance Statement 25 Jul 2019 4:33PM $0.120 $0.130 risen by 8.33%
$67 Notice of Annual General Meeting/Proxy Form 25 Jul 2019 4:32PM $0.120 $0.130 risen by 8.33%
$67 Annual Report to Shareholders - YE 31 March 2019 25 Jul 2019 4:32PM $0.120 $0.130 risen by 8.33%
$67 Amplia Therapeutics Reports Lead Candidate Preclinical Data 23 Jul 2019 9:47AM $0.125 $0.130 risen by 4%
$67 Amplia to present to Bioshares Biotech Summit 22 Jul 2019 9:33AM $0.115 $0.130 risen by 13.04%
$67 Update - July 2019 Newsletter 9 Jul 2019 10:06AM $0.093 $0.130 risen by 39.78%
$67 Letter to Shareholders - Rights Issue 1 Jul 2019 3:47PM $0.097 $0.130 risen by 34.02%
$67 Appendix 3B - Rights Issue 28 Jun 2019 8:30AM $0.095 $0.130 risen by 36.84%
$67 Rights Issue Prospectus 28 Jun 2019 8:29AM $0.095 $0.130 risen by 36.84%
$67 Financial Report Year Ended 31 March 2019 27 Jun 2019 7:23PM $0.095 $0.130 risen by 36.84%
$67 Dr John Lambert appointed as new CEO 24 Jun 2019 9:55AM $0.100 $0.130 risen by 30%
$67 Preliminary Rights Issue Details 17 Jun 2019 1:41PM $0.105 $0.130 risen by 23.81%
$67 Placement Cleansing Notice 14 Jun 2019 4:19PM $0.105 $0.130 risen by 23.81%
$67 Appendix 3B - Placement $360k 14 Jun 2019 4:19PM $0.105 $0.130 risen by 23.81%
$67 Capital Raising for Clinical-Enabling Studies 12 Jun 2019 10:15AM $0.110 $0.130 risen by 18.18%
$67 Preliminary Final Report - Year Ended 31 March 2019 29 May 2019 6:48PM $0.120 $0.130 risen by 8.33%
$67 Appendix 4C - Quarterly Statement of Cash Flows 30 Apr 2019 8:24AM $0.135 $0.130 fallen by 3.70%

476 - 500 of 536 results

Page 20 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.